Search results for "Clinical Science"

showing 10 items of 105 documents

Xenon treatment improves short-term and long-term outcomes in a rodent model of traumatic brain injury

2018

Science & TechnologyTraumatic brain injurybusiness.industrySITE1103 Clinical SciencesRodent modelmedicine.diseaseCOMPETITIVE-INHIBITIONTerm (time)D-ASPARTATE RECEPTORAnesthesiology and Pain MedicineAnesthesiologyAnesthesiamedicineLong term outcomesbusinessLife Sciences & BiomedicineBritish Journal of Anaesthesia
researchProduct

Predictor variables for half marathon race time in recreational female runners

2011

Import JabRef | WosArea General and Internal Medicine; International audience; INTRODUCTION: The relationship between skin-fold thickness and running performance has been investigated from 100 m to the marathon distance, except the half marathon distance. OBJECTIVE: To investigate whether anthropometry characteristics or training practices were related to race time in 42 recreational female half marathoners to determine the predictor variables of half-marathon race time and to inform future novice female half marathoners. METHODS: Observational field study at the 'Half Marathon Basel' in Switzerland. RESULTS: In the bivariate analysis, body mass (r = 0.60), body mass index (r = 0.48), body …

Time FactorsTRAINING CHARACTERISTICSPhysical fitnessLEVEL2700 General MedicineRunningEndurance0302 clinical medicineSkin fold030212 general & internal medicineSKINFOLD THICKNESSES2. Zero hungerlcsh:R5-920AnthropometryGeneral MedicineClinical ScienceCircumference3. Good healthSkinfold ThicknessSkinfold thicknessCIRCUMFERENCEBody fat[ SCCO.NEUR ] Cognitive science/NeuroscienceDISTANCE RUNNING PERFORMANCEFemalelcsh:Medicine (General)Adult11035 Institute of General Practicemedicine.medical_specialtyULTRAMARATHONERSeducationECONOMY610 Medicine & healthPredictor variablesAthletic PerformanceCAPACITY03 medical and health sciencesAthletemedicineHumansbusiness.industryUpper body[SCCO.NEUR]Cognitive science/NeuroscienceGender030229 sport sciencesAnthropometryBODY-MASSPhysical FitnessPhysical therapyRecreationUPPER ARMEpidemiologic MethodsbusinessBody mass indexhuman activities
researchProduct

CNN-Based Prostate Zonal Segmentation on T2-Weighted MR Images: A Cross-Dataset Study

2020

Prostate cancer is the most common cancer among US men. However, prostate imaging is still challenging despite the advances in multi-parametric magnetic resonance imaging (MRI), which provides both morphologic and functional information pertaining to the pathological regions. Along with whole prostate gland segmentation, distinguishing between the central gland (CG) and peripheral zone (PZ) can guide toward differential diagnosis, since the frequency and severity of tumors differ in these regions; however, their boundary is often weak and fuzzy. This work presents a preliminary study on deep learning to automatically delineate the CG and PZ, aiming at evaluating the generalization ability o…

Urologic DiseasesComputer scienceContext (language use)32 Biomedical and Clinical Sciences-Convolutional neural networkDeep convolutional neural networks Prostate zonal segmentation Cross-dataset generalizationProstate cancer46 Information and Computing SciencesProstateDeep convolutional neural networksmedicineAnatomical MRISegmentationProstate zonal segmentation; Prostate cancer; Anatomical MRI; Deep convolutional neural networks; Cross-dataset generalization;3202 Clinical SciencesCancerSettore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniProstate cancerSettore INF/01 - Informaticamedicine.diagnostic_testbusiness.industryDeep learningINF/01 - INFORMATICAMagnetic resonance imagingPattern recognitionmedicine.disease3211 Oncology and Carcinogenesismedicine.anatomical_structureCross-dataset generalizationProstate zonal segmentationBiomedical ImagingArtificial intelligenceDeep convolutional neural networkbusinessT2 weightedAnatomical MRI; Cross-dataset generalization; Deep convolutional neural networks; Prostate cancer; Prostate zonal segmentation
researchProduct

Sporotrichoid Cases of Mycobacterium Marinum Skin Infection.

2010

Mycobacterium marinum belongs to the slow growth photochromogenous mycobacteria group. It is pathogenic for fish and human beings in which it can cause cutaneous nodular and ulcerative lesions, sometimes with sporotrichoid arrangement. We report three cases of sporotrichoid Mycobacterium marinum infections successfully treated with prolonged antibiotic therapy. Tropical fish aquaria and, more in general, the water environment were identified as the source of infection.

biologyClinical scienceGeneral MedicineSkin infectionbiology.organism_classificationmedicine.diseaseOriginal researchMicrobiologymedicineSettore MED/35 - Malattie Cutanee E VenereeCancer geneMycobacterium marinum sporotrichoid mycobacteriosis swimming pool granuloma.Medical journalMycobacterium marinum
researchProduct

Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism

2018

Objective: To examine cognitive deficits and associated brain activity in fragile X-associated tremor/ataxia syndrome (FXTAS) patients with parkinsonism (FXTp+), in relation to FXTAS patients without parkinsonism (FXTp-), and normal elderly controls (NC). Methods: Retrospective reviews were performed in 65 FXTAS patients who participated in the event-related brain potential (ERP) study and also had either a videotaped neurological examination or a neurological examination for extrapyramidal signs. Parkinsonism was defined as having bradykinesia with at least one of the following: rest tremor, postural instability, hypermyotonia, or rigidity. Eleven FXTp+ patients were identified and compare…

cognition0301 basic medicineAgingmedicine.medical_specialtyAtaxialcsh:QH426-470Clinical SciencesNeurodegenerativeAudiologysemantic processingVerbal learningBasic Behavioral and Social Science03 medical and health sciencesRare Diseasesevent-related potential0302 clinical medicineClinical ResearchBehavioral and Social ScienceGeneticsmedicine2.1 Biological and endogenous factorsAetiologyLate positive componentparkinsonismGenetics (clinical)Original ResearchParkinson's DiseaseCalifornia Verbal Learning Testbusiness.industryParkinsonismNeurosciencesevent-related potential (ERP)medicine.diseaseFMR1Brain Disorderslcsh:Genetics030104 developmental biologyNeurologicalMolecular MedicineMental healthmedicine.symptomVerbal memorybusinessFMR1 premutationLaw030217 neurology & neurosurgeryExecutive dysfunctionFrontiers in Genetics
researchProduct

Medicine of the future: How and who is going to treat us?

2023

Medicine’s ability to quickly respond to challenges raises questions from researchers, practitioners, and society as a whole. Our task in this study was to identify key and atypical current factors influencing the development of medicine and to predict the development of medicine in the short, medium, and long term. To implement our study, we selected 22 medical experts and applied the three-level Delphi method. The current trends caused by COVID-19 have a short-term impact, but they will launch other drivers that will transform the healthcare industry. Well-being technologies, data-informed personalization, and climate change will become key drivers for the development of medicine over the…

futuremedicineSociology and Political ScienceterveydenhuoltoforecasthealthcareGeneral Social SciencesGeneral Decision Sciencesennusteet32 Biomedical and Clinical Sciences3 Good Health and Well BeinglääketiedeDevelopmentDelphiGeneric health relevancetulevaisuusBusiness and International Management3202 Clinical Sciences48 Law and Legal StudiesFutures
researchProduct

Nanoparticles as Contrast Agents for MRI of Atherosclerotic Lesions

2008

Nanoparticle contrast agents for MRI may aid in identifying atherosclerotic lesions that give rise to ischemic events by means of penetration and retention in the plaque. These imaging agents may provide valuable information regarding plaque characteristics which can help determine the risk of plaque rupture. By increasing molecular flexibility or adding a means of specifically targeting ligands via antibody or peptide, nanoparticles can enhance certain regions of the atherosclerotic plaque. The development of single contrast agents detectable with multiple imaging modalities may further improve our ability to detect and characterize atherosclerosis in clinical and preclinical applications.…

lcsh:Diseases of the circulatory (Cardiovascular) systembusiness.industryPlaque ruptureClinical scienceBioinformaticsOriginal researchImaging modalitieslcsh:RC666-701Drug deliverySingle contrastMedicineCancer geneCardiology and Cardiovascular MedicinebusinessTargeting ligandsClinical medicine. Cardiology
researchProduct

Immunosenescence and Cytomegalovirus

2010

Since Looney at al. published their seminal paper a decade ago [1] it has become clear that many of the differences in T cell immunological parameters observed between young and old people are related to the age-associated increasing prevalence of infection with the persistent β-herpesvirus HHV-5 (Cytomegalovirus). Ten years later, studies suggest that hallmark age-associated changes in peripheral blood T cell subset distribution may not occur at all in people who are not infected with this virus [[2]; Derhovanessian et al., in press]. Whether the observed changes are actually caused by CMV is an open question, but very similar, rapid changes observed in uninfected patients receiving CMV-in…

lcsh:Immunologic diseases. AllergyAgingCMV ImmunosenescenceageingT cellImmunologyCongenital cytomegalovirus infectionYellow fever vaccine32 Biomedical and Clinical Scienceslcsh:GeriatricsVirusImmune systemMedicine3202 Clinical Sciencesbiologybusiness.industryvirus diseasesImmunosenescenceBiological Sciencesmedicine.disease3204 Immunologylcsh:RC952-954.6Ageingmedicine.anatomical_structureImmunologyT cell subsetQR180biology.proteinCommentaryAntibodylcsh:RC581-607businessmedicine.drugImmunity & ageing
researchProduct

Paroxetine Administration Affects Microbiota and Bile Acid Levels in Mice.

2020

Recent interest in the role of microbiota in health and disease has implicated gut microbiota dysbiosis in psychiatric disorders including major depressive disorder. Several antidepressant drugs that belong to the class of selective serotonin reuptake inhibitors have been found to display antimicrobial activities. In fact, one of the first antidepressants discovered serendipitously in the 1950s, the monoamine-oxidase inhibitor Iproniazid, was a drug used for the treatment of tuberculosis. In the current study we chronically treated DBA/2J mice for 2 weeks with paroxetine, a selective serotonin reuptake inhibitor, and collected fecal pellets as a proxy for the gut microbiota from the animals…

medicine.drug_classlcsh:RC435-571Serotonin reuptake inhibitorClinical SciencesmicrobiomeGut floraPharmacology03 medical and health sciences0302 clinical medicineRare Diseaseslcsh:PsychiatrymedicinePsychologyMicrobiomeCancerOriginal ResearchPsychiatrybile acidsantidepressantbiologyBile acidbusiness.industryDepressionbiology.organism_classificationmedicine.diseaseParoxetinemetabolomics030227 psychiatryColo-Rectal CancerPsychiatry and Mental healthMental HealthGood Health and Well Being5.1 PharmaceuticalsPublic Health and Health ServicesAntidepressantDevelopment of treatments and therapeutic interventionsbusinessDigestive DiseasesDysbiosis030217 neurology & neurosurgeryBehavioural despair testmedicine.drugparoxetineFrontiers in psychiatry
researchProduct

Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial

2021

Abstract Aims  Hyperkalaemia is a common complication of type 2 diabetes mellitus (T2DM) and limits the optimal use of agents that block the renin–angiotensin–aldosterone system, particularly in patients with chronic kidney disease (CKD). In patients with CKD, sodium‒glucose cotransporter 2 (SGLT2) inhibitors provide cardiorenal protection, but whether they affect the risk of hyperkalaemia remains uncertain. Methods and results  The CREDENCE trial randomized 4401 participants with T2DM and CKD to the SGLT2 inhibitor canagliflozin or matching placebo. In this post hoc analysis using an intention-to-treat approach, we assessed the effect of canagliflozin on a composite outcome of time to eith…

medicine.medical_specialtyCardiac & Cardiovascular SystemsINHIBITIONRATIONALEPlaceboHYPERKALEMIAMECHANISMSHyperkalaemiaChronic kidney diseaseInternal medicineDiabetes mellitusType 2 diabetes mellitusEND-POINTSPost-hoc analysismedicineHumansCanagliflozinRenal Insufficiency Chronic1102 Cardiorespiratory Medicine and HaematologySodium-Glucose Transporter 2 InhibitorsCanagliflozinOUTCOMESScience & Technologybusiness.industryType 2 Diabetes Mellitus1103 Clinical Sciencesmedicine.diseaseCardiovascular System & HematologyDiabetes Mellitus Type 2Serum potassiumCardiovascular System & CardiologyPotassiumCardiology and Cardiovascular MedicinebusinessComplicationLife Sciences & BiomedicineSGLT2 inhibitorsKidney diseasemedicine.drugEuropean Heart Journal
researchProduct